Optimization and fabrication of alginate scaffold for alveolar bone regeneration with sufficient drug release

dc.contributor.authorSoleimani, Maryam
dc.contributor.authorAsgharzadeh Salmasi, Ariyan
dc.contributor.authorAsghari, Samaneh
dc.contributor.authorJoneidi Yekta, Hamed
dc.contributor.authorKamyab Moghadas, Bahareh
dc.contributor.authorShahriari, Sheyda
dc.contributor.authorKhandan, Amirsalar
dc.date.accessioned2026-02-06T18:36:04Z
dc.date.issued2021
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractBone tissues, with their porous structure and the crucial role of producing and releasing blood elements into the bloodstream, can act as a suitable candidate for drug delivery stations in all parts of the body. Making an appropriate osteoconductive scaffold with drug delivery is the basis of this study for designing such materials. In this research, bone scaffolds containing drugs and magnetite nanoparticles were designed and produced for bone tissue approaches. As a new class of treatment for bone defects or deformity, calcium silicate ceramics (CSC) have been able to attract a lot of attention among researchers as a viable solution. With the incorporation of metal oxides (like Fe3O4: magnetite nanoparticles; MNPs) into the base binary xCaO-ySiO(2)-MgO as well as the substitution of calcium ions, CSCs can be fabricated. In the current work, the scanning electron microscope (SEM) and X-ray diffraction (XRD) technique were used to determine the phase and morphology of the porous scaffolds for dental fracture. The observation shows that the compressive strength and elastic modulus increase from 0.9 to 1.76 MPa and 59 to 81 MPa, respectively. The SEM images proved that the porosity dimensions were reduced from sample 0 wt% to sample 15 wt% (From 85 to 70%). Also, the absorbance test was found to be increased from 0 to 15 wt% sample in the PBS immersion solution. The obtained results indicated that the samples with a maximum of 10 wt% MNPs might release the drug more comfortably, which can be reported as a suitable candidate for bone tissue application.
dc.identifier.doi10.1007/s40089-021-00342-0
dc.identifier.endpage305
dc.identifier.issn2008-9295
dc.identifier.issn2228-5326
dc.identifier.issue3
dc.identifier.orcid0000-0003-2302-5983
dc.identifier.orcid0000-0003-4938-4247
dc.identifier.scopus2-s2.0-85106716140
dc.identifier.scopusqualityQ1
dc.identifier.startpage295
dc.identifier.urihttps://doi.org/10.1007/s40089-021-00342-0
dc.identifier.urihttps://hdl.handle.net/11129/12177
dc.identifier.volume11
dc.identifier.wosWOS:000655796100001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSpringer International Publishing Ag
dc.relation.ispartofInternational Nano Letters
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectDrug delivery
dc.subjectPharmacological knowledge
dc.subjectBone substitute
dc.subjectTissue engineering
dc.subjectNatural polymer
dc.titleOptimization and fabrication of alginate scaffold for alveolar bone regeneration with sufficient drug release
dc.typeArticle

Files